CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Linjing Mu

ORCID: 0000-0001-5354-1546↗

Public evidence

6 connected articles

Exploration of (R)-[<sup>11</sup>C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates.2025 · Europe PMC Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research.2025 · Europe PMC In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.2022 · Europe PMC Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease.2022 · Europe PMC Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging.2016 · Europe PMC Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.2014 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Linjing Mu - Medical Cannabis Research Engine